Market Overview:
The global forskolin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing awareness about the health benefits of forskolin, rising demand for weight management supplements, and growing prevalence of respiratory disorders. However, factors such as high cost and limited availability may restrain the growth of this market during the forecast period. The global forskolin market is segmented on the basis of type, application, and region.
Product Definition:
Forskolin is a natural supplement derived from the plant Coleus forskohlii. It has been used since ancient times to treat a variety of disorders, and is now marketed as a weight loss aid. Forskolin increases levels of cyclic adenosine monophosphate (cAMP), which activates protein kinase A (PKA) and leads to the release of stored fat from adipose tissue. cAMP also stimulates lipolysis (breakdown of fats) in skeletal muscle.
Low Purity(?97%):
Forskolin is a plant-based compound, extracted from the root of beets. It's main function in the body is to help regulate blood sugar levels and heart rate. The product also has antioxidant properties that can help prevent cell damage and aging problems.
Purity(>97% and
Purity level of forskolin extract is a measure to evaluate the quality and standardization of the product. It helps in minimizing the chances of negative effects from contaminants present in raw materials or during production process. Purity levels ranging from >97% to 99%.
Application Insights:
The weight management application segment led the global forskolin market in 2017. The rising prevalence of obesity and other related health issues is expected to be a major factor driving the demand for Forskolin in weight management applications over the forecast period.
The respiratory disorders application segment is projected to witness significant growth over the forecast period owing to increasing incidences of chronic respiratory diseases, such as asthma, COPD and bronchitis among children and adults across various regions including North America, Europe, Asia Pacific and Middle East & Africa. In addition, increasing research & development activities by various companies are expected to propel market growth over the coming years.
Forskolin has been proven effective against constipation by improving bowel movements naturally without causing diarrhea or abdominal pain which makes it suitable for use in treating digestive disorders especially irritable bowel syndrome (IBS) without producing any negative side effects like drug-related ones which will drive its demand further.
Regional Analysis:
North America dominated the global forskolin market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to rising consumer awareness regarding health and fitness along with increasing prevalence of obesity and diabetes in the region. In addition, growing number of clinical studies on forskolin coupled with high disposable income is also driving growth in this region. Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to rapid economic development coupled with improving healthcare infrastructure especially in India & China which are major importers & producers as well as consumers of forskolin globally in this region forskolin has been widely used by herbal practitioners due its ability to treat various disorders such as respiratory problems, weight management disorder etc.
Growth Factors:
- Increasing awareness about the health benefits of Forskolin is expected to drive its demand in the coming years.
- Rising prevalence of obesity and other lifestyle diseases is anticipated to fuel the growth of Forskolin market.
- Growing popularity of natural and herbal supplements is projected to boost the demand for Forskolin in the near future.
- increasing research on potential health benefits of Forskolin is likely to propel its demand over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Forskolin Market Research Report
By Type
Low Purity(?97%), Purity(>97% and <99%), High Purity(More than or euqal to99%), Others
By Application
Weight Management, Respiratory Disorders, Digestive Disorders, Insomnia, Others
By Companies
Sabinsa Corporation, Bioprex Labs, Nutra Green Biotechnology, Varion Lifesciences, Glentham Life Sciences, Manus Aktteva Biopharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Forskolin Market Report Segments:
The global Forskolin market is segmented on the basis of:
Types
Low Purity(?97%), Purity(>97% and <99%), High Purity(More than or euqal to99%), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Weight Management, Respiratory Disorders, Digestive Disorders, Insomnia, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sabinsa Corporation
- Bioprex Labs
- Nutra Green Biotechnology
- Varion Lifesciences
- Glentham Life Sciences
- Manus Aktteva Biopharma
Highlights of The Forskolin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low Purity(?97%)
- Purity(>97% and <99%)
- High Purity(More than or euqal to99%)
- Others
- By Application:
- Weight Management
- Respiratory Disorders
- Digestive Disorders
- Insomnia
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Forskolin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Forskolin is a natural compound found in the roots of plants. Forskolin has been shown to have anti-inflammatory and antioxidant properties, which may help reduce the risk of heart disease and other chronic diseases.
Some of the major companies in the forskolin market are Sabinsa Corporation, Bioprex Labs, Nutra Green Biotechnology, Varion Lifesciences, Glentham Life Sciences, Manus Aktteva Biopharma.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Forskolin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Forskolin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Forskolin Market - Supply Chain
4.5. Global Forskolin Market Forecast
4.5.1. Forskolin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Forskolin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Forskolin Market Absolute $ Opportunity
5. Global Forskolin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Forskolin Market Size and Volume Forecast by Type
5.3.1. Low Purity(?97%)
5.3.2. Purity(>97% and <99%)
5.3.3. High Purity(More than or euqal to99%)
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Forskolin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Forskolin Market Size and Volume Forecast by Application
6.3.1. Weight Management
6.3.2. Respiratory Disorders
6.3.3. Digestive Disorders
6.3.4. Insomnia
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Forskolin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Forskolin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Forskolin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Forskolin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Forskolin Demand Share Forecast, 2019-2026
9. North America Forskolin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Forskolin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Forskolin Market Size and Volume Forecast by Application
9.4.1. Weight Management
9.4.2. Respiratory Disorders
9.4.3. Digestive Disorders
9.4.4. Insomnia
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Forskolin Market Size and Volume Forecast by Type
9.7.1. Low Purity(?97%)
9.7.2. Purity(>97% and <99%)
9.7.3. High Purity(More than or euqal to99%)
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Forskolin Demand Share Forecast, 2019-2026
10. Latin America Forskolin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Forskolin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Forskolin Market Size and Volume Forecast by Application
10.4.1. Weight Management
10.4.2. Respiratory Disorders
10.4.3. Digestive Disorders
10.4.4. Insomnia
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Forskolin Market Size and Volume Forecast by Type
10.7.1. Low Purity(?97%)
10.7.2. Purity(>97% and <99%)
10.7.3. High Purity(More than or euqal to99%)
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Forskolin Demand Share Forecast, 2019-2026
11. Europe Forskolin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Forskolin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Forskolin Market Size and Volume Forecast by Application
11.4.1. Weight Management
11.4.2. Respiratory Disorders
11.4.3. Digestive Disorders
11.4.4. Insomnia
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Forskolin Market Size and Volume Forecast by Type
11.7.1. Low Purity(?97%)
11.7.2. Purity(>97% and <99%)
11.7.3. High Purity(More than or euqal to99%)
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Forskolin Demand Share, 2019-2026
12. Asia Pacific Forskolin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Forskolin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Forskolin Market Size and Volume Forecast by Application
12.4.1. Weight Management
12.4.2. Respiratory Disorders
12.4.3. Digestive Disorders
12.4.4. Insomnia
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Forskolin Market Size and Volume Forecast by Type
12.7.1. Low Purity(?97%)
12.7.2. Purity(>97% and <99%)
12.7.3. High Purity(More than or euqal to99%)
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Forskolin Demand Share, 2019-2026
13. Middle East & Africa Forskolin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Forskolin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Forskolin Market Size and Volume Forecast by Application
13.4.1. Weight Management
13.4.2. Respiratory Disorders
13.4.3. Digestive Disorders
13.4.4. Insomnia
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Forskolin Market Size and Volume Forecast by Type
13.7.1. Low Purity(?97%)
13.7.2. Purity(>97% and <99%)
13.7.3. High Purity(More than or euqal to99%)
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Forskolin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Forskolin Market: Market Share Analysis
14.2. Forskolin Distributors and Customers
14.3. Forskolin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sabinsa Corporation
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bioprex Labs
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nutra Green Biotechnology
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Varion Lifesciences
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Glentham Life Sciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Manus Aktteva Biopharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
